Overview

Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis

Status:
Recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
This study is a single center, randomized, double-blind, Vehicle controlled,, single and multiple dose clinical study.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu vcare pharmaceutical technology co., LTD